[
  {
    "date": "2023-12-30",
    "symbol": "RLAY",
    "period": "FY",
    "netincomeloss": -341973000,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "RELAY THERAPEUTICS, INC.",
    "entitycentralindexkey": 1812364,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large Accelerated Filer",
    "entitywellknownseasonedissuer": "Yes",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "RLAY",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39385",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "47-3923475",
    "entityaddressaddressline1": "399 Binney Street",
    "entityaddressaddressline2": "2nd Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "370-8837",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Boston, Massachusetts",
    "documentfinstmterrorcorrectionflag": "false",
    "cashandcashequivalentsatcarryingvalue": 143736000,
    "investments": 606350000,
    "prepaidexpensecurrent": 16702000,
    "otherassetscurrent": 3315000,
    "assetscurrent": 770103000,
    "propertyplantandequipmentnet": 10901000,
    "operatingleaserightofuseasset": 57969000,
    "restrictedcashnoncurrent": 2707000,
    "finitelivedintangibleassetsnet": 2300000,
    "assets": 843980000,
    "accountspayablecurrent": 9211000,
    "accruedliabilitiescurrent": 14890000,
    "operatingleaseliabilitycurrent": 4964000,
    "otherliabilitiescurrent": 1204000,
    "liabilitiescurrent": 30269000,
    "operatingleaseliabilitynoncurrent": 48502000,
    "businesscombinationcontingentconsiderationliability": 13206000,
    "liabilities": 91977000,
    "commonstockvalue": 127000,
    "additionalpaidincapital": 2152654000,
    "accumulatedothercomprehensiveincomelossnetoftax": -196000,
    "retainedearningsaccumulateddeficit": -1400582000,
    "stockholdersequity": 752003000,
    "liabilitiesandstockholdersequity": 843980000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesissued": 127462409,
    "commonstocksharesoutstanding": 127462409,
    "revenuefromcontractwithcustomerexcludingassessedtax": 25546000,
    "revenuefromcontractwithcustomerproductandserviceextensiblelist": "http://fasb.org/us-gaap/2023#LicenseAndServiceMember",
    "revenues": 25546000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 330018000,
    "changeinfairvalueofcontingentconsiderationliabilities": -6422000,
    "generalandadministrativeexpense": 74950000,
    "operatingexpenses": 398546000,
    "operatingincomeloss": -373000000,
    "interestincomeother": 31045000,
    "otherincomeexpense": -18000,
    "othernonoperatingincomeexpense": 31027000,
    "earningspersharebasic": -2.79,
    "earningspersharediluted": -2.79,
    "weightedaveragenumberofsharesoutstandingbasic": 122576527,
    "weightedaveragenumberofsharesoutstandingdiluted": 122576527,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": 10224000,
    "othercomprehensiveincomelossnetoftax": 10224000,
    "comprehensiveincomenetoftax": -331749000,
    "sharesoutstanding": 127462409,
    "issuanceofcommonstockuponmilestoneachievementshares": 1797064,
    "issuanceofcommonstockuponmilestoneachievement": 2000,
    "stockissuedduringperiodvaluenewissues": 3000,
    "stockissuedduringperiodsharesnewissues": 3026072,
    "stockissuedduringperiodvaluestockoptionsexercised": 1000,
    "stockissuedduringperiodsharesstockoptionsexercised": 399498,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 2486000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 244125,
    "vestingofrestrictedstockunitsshares": 883416,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 86031000,
    "debtsecuritiesavailableforsaleunrealizedgainloss": 10224000,
    "sharebasedcompensation": 86031000,
    "depreciation": 5269000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 10763000,
    "increasedecreaseinaccountsreceivable": -306000,
    "increasedecreaseincommoditycontractassetsandliabilities": -4913000,
    "increasedecreaseinprepaidexpense": 4648000,
    "increasedecreaseinoperatingleaseassetsandliabilitiesnet": -1509000,
    "increasedecreaseinaccountspayable": -2394000,
    "increasedecreaseinaccruedliabilities": -32144000,
    "netcashprovidedbyusedinoperatingactivities": -300316000,
    "paymentstoacquirepropertyplantandequipment": 4126000,
    "paymentstoacquireinvestments": 385542000,
    "proceedsfromsaleandmaturityofotherinvestments": 647302000,
    "netcashprovidedbyusedininvestingactivities": 257634000,
    "proceedsfromissuanceofcommonstockthroughatthemarketofferingsnet": 30281000,
    "proceedsfromissuanceofcommonstockuponexerciseofstockoptions": 1986000,
    "proceedsfromemployeestockpurchaseplan": 2486000,
    "netcashprovidedbyusedinfinancingactivities": 34753000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -7929000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 146443000,
    "periodicchangetoadditionsofpropertyandequipmentincurrentliabilities": 410000,
    "restrictedcash": 2707000,
    "numberofdiscoverystageprograms": 7,
    "numberofoperatingsegments": 1,
    "cashandcashequivalentsmaturitydatedescription": "The Company considers all short-term, highly liquid investments with original maturities of 90 days or less at acquisition date to be cash equivalents.",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "propertyplantandequipmentusefullife": "P3Y",
    "incometaxexaminationlikelihoodofunfavorablesettlement": "greater than 50%",
    "cashandcashequivalentsfairvaluedisclosure": 140466000,
    "investmentsfairvaluedisclosure": 416008000,
    "assetsfairvaluedisclosure": 140466000,
    "businesscombinationcontingentmilestonepayments": 8206000,
    "nonfinancialliabilitiesfairvaluedisclosure": 8206000,
    "businesscombinationcontingentconsiderationarrangementsdescription": "The outstanding Contingent Milestone Payments are payable in shares of the Company's common stock based on a fixed amount assigned to each milestone and the volume weighted-average closing price of the Company’s common stock for a specified period prior to the milestone achievement.",
    "numberofshareswouldbeissueduponmilestoneachievements": 5272112,
    "averagestockpriceuponmilestonesettlement": 11.29,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliability1": -6422000,
    "commonstockissueduponmilestoneachievement": -12750000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 314957000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 83000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 482000,
    "availableforsalesecuritiesdebtsecurities": 314558000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionnumberofpositions": 70,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 172625000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12monthsaccumulatedloss": 371000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlonger": 27822000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlongeraccumulatedloss": 169000,
    "debtsecuritiesavailableforsaleunrealizedlossposition": 200447000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionaccumulatedloss": 540000,
    "propertyplantandequipmentgross": 25558000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 23582000,
    "accruedexternalresearchanddevelopmentexpensecurrent": 12509000,
    "accruedconsultingandprofessionalservices": 886000,
    "accruedcompensationcosts": 702000,
    "accruedotherexpensescurrent": 793000,
    "commonstockvotingrights": "Each share of common stock entitles the stockholder to one vote on all matters submitted to a vote of the Company’s stockholders.",
    "commonstockrestrictionperiod": "P4Y",
    "saleofstockpricepershare": 10.26,
    "proceedsfromissuanceofcommonstock": 30300000,
    "commissionsandotherofferingexpenses": 800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 9160736,
    "allocatedsharebasedcompensationexpense": 48351000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 4400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 12.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 10500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 73100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y4M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 4129710,
    "sharebasedcompensationarrangementbysharebasedpaymentawardrsusgrantsinperiodgross": 405770,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.035,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgrantdatefairvalue": 12.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantdatefairvalue": 16.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionscontractualterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 20.45,
    "shareprice": 20.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 648422,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 282314,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 883652,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 12391815,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 6651356,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 5740459,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 18.56,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 18.64,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.95,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 23.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 16.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 20.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y6M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y8M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm": "P8Y7M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 18907000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 18559000,
    "sharebasedcompensationarrangementbysharebasedpaymentsawardoptionsnonvestedintrinsicvalue1": 348000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.033,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.741,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.798,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 2992247,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 2591453,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 19.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 17.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 21.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 24,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 15610586,
    "collaborativearrangementnatureandpurpose": "In December 2020, the Company and Genentech, Inc. (\"Genentech\") entered into the Collaboration and License Agreement (as amended from time to time, the \"Genentech Agreement\"), which granted Genentech a license to develop and commercialize GDC-1971 (migoprotafib, formerly known as RLY-1971).",
    "nonrefundablepayments": 86800000,
    "milestonespaid": 25000000,
    "additionalpaymentstobereceiveduponachievementofotherspecifieddevelopmentcommercializationandsalesbasedmilestonesdoesnotexerciseoptiontoparticipateincollaboration": 675000000,
    "collaborationsagreementtransactionprice": 111800000,
    "contractwithcustomercashreceived": 5000000,
    "researchanddevelopmentarrangementcontracttoperformforothersrenewalperiod": "P1Y",
    "potentialdevelopmentmilestonepayments": 7300000,
    "commonstocksharesissueduponconversion": 3281253,
    "milestonepaymentdueuponspecifiedregulatorymilestoneachievementforfirstthreetargets": 7300000,
    "milestonepaymentdueuponspecifiedregulatorymilestoneachievementforeachtargetafterfirstthree": 6300000,
    "researchanddevelopmentexpense": 9500000,
    "lettersofcreditoutstandingamount": 900000,
    "operatingleasepayments": 4300000,
    "operatingleaseweightedaverageremainingleaseterm1": "P5Y3M29D",
    "operatingleaseweightedaveragediscountratepercent": 0.104,
    "operatingleaseliability": 18887000,
    "operatingleasecost": 3631000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 4377000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 4503000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 4634000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 4768000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 4906000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 1651000,
    "lesseeoperatingleaseliabilitypaymentsdue": 24839000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 5952000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 498000000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 43100000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 454900000,
    "deferredtaxassetsoperatinglosscarryforwardsbeginningtoexpireyear": 2035,
    "deferredtaxassetstaxcreditsresearchanddevelopmentbeginningtoexpireyear": 2035,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 559700000,
    "deferredtaxassetstaxcreditcarryforwardsresearchanddevelopment": 38900000,
    "increaseindeferredtaxassetsvaluationallowance": 69300000,
    "incometaxexaminationdescription": "There are currently no pending tax examinations.",
    "caresactnetoperatinglossescarrybackperiod": "P5Y",
    "caresactpercentageofeliminatesoftaxableincome": 0.8,
    "caresactmaximumpercentageofinterestdeductedbytaxpayers": 0.5,
    "caresactpercentageofinterestdeductedbytaxpayers": 0.3,
    "caresactpercentageofcorporatecharitabledeductionlimit": 0.25,
    "caresactperiodofqualifiedimprovementpropertyforcostrecovery": "P15Y",
    "caresactpercentageofbonusdepreciation": 1,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.037,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.203,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.045,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.017,
    "effectiveincometaxratereconciliationpermanentdifferences": 0.002,
    "deferredtaxassetsoperatinglosscarryforwards": 141453000,
    "deferredtaxassetstaxcreditcarryforwards": 45969000,
    "deferredtaxassetscapitalizedresearchanddevelopmentexpense": 90273000,
    "deferredtaxassetsleaseliability": 12914000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 19448000,
    "deferredtaxassetsgoodwillandintangibleassets": 1261000,
    "deferredtaxassetsdepreciationandamortization": 505000,
    "deferredtaxassetsother": 263000,
    "deferredtaxassetsgross": 312086000,
    "deferredtaxassetsvaluationallowance": 299829000,
    "deferredtaxassetsnet": 12257000,
    "deferredtaxliabilitiesoperatingleaseassets": 12257000,
    "deferredincometaxliabilities": 12257000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 2600000
  },
  {
    "date": "2022-12-30",
    "symbol": "RLAY",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "RELAY THERAPEUTICS, INC.",
    "entitycentralindexkey": 1812364,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large Accelerated Filer",
    "entitywellknownseasonedissuer": "Yes",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "RLAY",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39385",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "47-3923475",
    "entityaddressaddressline1": "399 Binney Street",
    "entityaddressaddressline2": "2nd Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "370-8837",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young",
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 151794000,
    "investments": 847123000,
    "accountsreceivablenetcurrent": 306000,
    "contractwithcustomerassetnet": 4913000,
    "prepaidexpensecurrent": 12110000,
    "otherassetscurrent": 3259000,
    "assetscurrent": 1019505000,
    "propertyplantandequipmentnet": 11634000,
    "operatingleaserightofuseasset": 63754000,
    "restrictedcashnoncurrent": 2578000,
    "finitelivedintangibleassetsnet": 2300000,
    "assets": 1099771000,
    "accountspayablecurrent": 10578000,
    "accruedliabilitiescurrent": 22703000,
    "operatingleaseliabilitycurrent": 4276000,
    "otherliabilitiescurrent": 26152000,
    "liabilitiescurrent": 63709000,
    "operatingleaseliabilitynoncurrent": 53466000,
    "businesscombinationcontingentconsiderationliability": 32378000,
    "liabilities": 149553000,
    "commonstockvalue": 121000,
    "additionalpaidincapital": 2019126000,
    "accumulatedothercomprehensiveincomelossnetoftax": -10420000,
    "retainedearningsaccumulateddeficit": -1058609000,
    "stockholdersequity": 950218000,
    "liabilitiesandstockholdersequity": 1099771000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesissued": 121112234,
    "commonstocksharesoutstanding": 121112234,
    "revenuefromcontractwithcustomerexcludingassessedtax": 1381000,
    "revenuefromcontractwithcustomerproductandserviceextensiblelist": "http://fasb.org/us-gaap/2022#LicenseAndServiceMember",
    "revenues": 1381000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 246355000,
    "changeinfairvalueofcontingentconsiderationliabilities": -11677000,
    "generalandadministrativeexpense": 65978000,
    "operatingexpenses": 300656000,
    "operatingincomeloss": -299275000,
    "interestincomeother": 8786000,
    "otherincomeexpense": -20000,
    "othernonoperatingincomeexpense": 8766000,
    "netincomeloss": -290509000,
    "netincomelossavailabletocommonstockholders": -290509000,
    "earningspersharebasic": -2.59,
    "earningspersharediluted": -2.59,
    "weightedaveragenumberofsharesoutstandingbasic": 112233649,
    "weightedaveragenumberofsharesoutstandingdiluted": 112233649,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": -9332000,
    "othercomprehensiveincomelossnetoftax": -9332000,
    "comprehensiveincomenetoftax": -299841000,
    "sharesoutstanding": 121112234,
    "stockissuedduringperiodsharesnewissues": 11320755,
    "stockissuedduringperiodvaluestockoptionsexercised": 1000,
    "stockissuedduringperiodsharesstockoptionsexercised": 757873,
    "issuanceofcommonstockuponmilestoneachievement": 6203000,
    "issuanceofcommonstockuponmilestoneachievementshares": 301939,
    "stockissuedduringperiodvaluenewissues": 11000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1686000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 123019,
    "vestingofrestrictedstockunitsshares": 398330,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 56138000,
    "debtsecuritiesavailableforsaleunrealizedgainloss": -9332000,
    "sharebasedcompensation": 56138000,
    "depreciation": 4130000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -1182000,
    "increasedecreaseinaccountsreceivable": -97000,
    "increasedecreaseincommoditycontractassetsandliabilities": 376000,
    "increasedecreaseinprepaidexpense": 2140000,
    "increasedecreaseinoperatingleaseassetsandliabilitiesnet": 8132000,
    "increasedecreaseinaccountspayable": 1989000,
    "increasedecreaseinaccruedliabilities": 20056000,
    "increasedecreaseindeferredrevenue": -248000,
    "netcashprovidedbyusedinoperatingactivities": -229490000,
    "paymentstoacquirepropertyplantandequipment": 9062000,
    "paymentstoacquireinvestments": 535419000,
    "proceedsfromsaleandmaturityofotherinvestments": 355736000,
    "netcashprovidedbyusedininvestingactivities": -188745000,
    "proceedsfromissuanceofcommonstockuponfollowonofferingnet": 284744000,
    "proceedsfromissuanceofcommonstockuponexerciseofstockoptions": 3480000,
    "proceedsfromstockplans": 1686000,
    "netcashprovidedbyusedinfinancingactivities": 289910000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -128325000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 154372000,
    "capitalexpendituresincurredbutnotyetpaid": 159000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 46626000,
    "restrictedcash": 2578000,
    "numberofdiscoverystageprograms": 3,
    "numberofoperatingsegments": 1,
    "cashandcashequivalentsmaturitydatedescription": "The Company considers all short-term, highly liquid investments with original maturities of 90 days or less at acquisition date to be cash equivalents.",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "propertyplantandequipmentusefullife": "P3Y",
    "incometaxexaminationlikelihoodofunfavorablesettlement": "greater than 50%",
    "cashandcashequivalentsfairvaluedisclosure": 118446000,
    "investmentsfairvaluedisclosure": 466603000,
    "assetsfairvaluedisclosure": 118446000,
    "businesscombinationcontingentmilestonepayments": 27378000,
    "nonfinancialliabilitiesfairvaluedisclosure": 27378000,
    "numberofcommonstockissueduponmilestoneachievements": 301939,
    "businesscombinationcontingentconsiderationarrangementsdescription": "The outstanding Contingent Milestone Payments are payable in shares of common stock based on a fixed amount assigned to each milestone and the average closing price of the Company’s common stock for the 5-day period prior to the milestone achievement.",
    "numberofshareswouldbeissueduponmilestoneachievement": 4954739,
    "averagestockpriceuponmilestonesettlement": 14.58,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliability1": -11677000,
    "commonstockissueduponmilestoneachievement": -6203000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 356728000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 9000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 5523000,
    "availableforsalesecuritiesdebtsecurities": 351214000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionnumberofpositions": 126,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlonger": 275445000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 143089000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12monthsaccumulatedloss": 1860000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlongeraccumulatedloss": 4578000,
    "debtsecuritiesavailableforsaleunrealizedlossposition": 418534000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionaccumulatedloss": 6438000,
    "propertyplantandequipmentgross": 21472000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 18389000,
    "accruedexternalresearchanddevelopmentexpensecurrent": 19276000,
    "accruedconsultingandprofessionalservices": 831000,
    "accruedcompensationcosts": 1043000,
    "accruedotherexpensescurrent": 1553000,
    "commonstockvotingrights": "Each share of common stock entitles the stockholder to one vote on all matters submitted to a vote of the Company’s stockholders.",
    "commonstockrestrictionperiod": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 10783577,
    "allocatedsharebasedcompensationexpense": 30671000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 15500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 13.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 8600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 66700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y5M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3658461,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9276552,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 551132,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4415876,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 4860676,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 18.33,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 20.58,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.47,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 32.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 13.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 22.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y10M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y11M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm": "P8Y8M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 34647000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 29401000,
    "sharebasedcompensationarrangementbysharebasedpaymentsawardoptionsnonvestedintrinsicvalue1": 5246000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.016,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.727,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.762,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1566760,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1389696,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 398330,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 115811,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 24.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 20.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 27.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 27.59,
    "weightedaveragenumberofdilutedsharesoutstanding": 112233649,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 11050735,
    "collaborativearrangementnatureandpurpose": "In December 2020, the Company and Genentech, Inc. (\"Genentech\") entered into the Collaboration and License Agreement (\"Genentech Agreement\"), which granted Genentech a license to develop and commercialize GDC-1971 (formerly known as RLY-1971).",
    "milestonepaymentreceivable": 5000000,
    "maximumadditionalamountreceiveduponmilestoneachievement": 685000000,
    "collaborationagreementtransactionprice": 86800000,
    "nonrefundablemilestoneforcompletionamount": 5000000,
    "variableconsiderationrelatedtoreimbursementsdueforresearchanddevelopmentservices": 1800000,
    "revenueremainingperformanceobligation": 83600000,
    "researchanddevelopmentexpense": 9400000,
    "cashreceivedformilestonepayment": 25000000,
    "researchanddevelopmentarrangementcontracttoperformforothersrenewalperiod": "P1Y",
    "potentialdevelopmentmilestonepayments": 7300000,
    "commonstocksharesissueduponconversion": 3281253,
    "milestonepaymentdueuponspecifiedregulatorymilestoneachievementforfirstthreetargets": 7300000,
    "milestonepaymentdueuponspecifiedregulatorymilestoneachievementforeachtargetafterfirstthree": 6300000,
    "lettersofcreditoutstandingamount": 900000,
    "operatingleasepayments": 4100000,
    "operatingleaseweightedaverageremainingleaseterm1": "P6Y3M29D",
    "operatingleaseweightedaveragediscountratepercent": 0.104,
    "operatingleaseliability": 21056000,
    "operatingleasecost": 3350000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 4254000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 4377000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 4503000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 4634000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 4768000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 6557000,
    "lesseeoperatingleaseliabilitypaymentsdue": 29093000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 8037000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 412000000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 43100000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 368900000,
    "deferredtaxassetsoperatinglosscarryforwardsbeginningtoexpireyear": 2035,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 501700000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 25900000,
    "increaseindeferredtaxassetsvaluationallowance": 87800000,
    "incometaxexaminationdescription": "There are currently no pending tax examinations.",
    "caresactnetoperatinglosscarrybackperiod": "P5Y",
    "caresactpercentageofeliminatesoftaxableincome": 0.8,
    "caresactmaximumpercentageofinterestdeductedbytaxpayers": 0.5,
    "caresactpercentageofinterestdeductedbytaxpayers": 0.3,
    "caresactpercentageofcorporatecharitabledeductionlimit": 0.25,
    "caresactperiodofqualifiedimprovementpropertyforcostrecovery": "P15Y",
    "caresactpercentageofbonusdepreciation": 1,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.065,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.302,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.042,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.021,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.006,
    "deferredtaxassetsoperatinglosscarryforwards": 119688000,
    "deferredtaxassetstaxcreditcarryforwards": 30593000,
    "deferredtaxassetscapitalizedresearchanddevelopmentexpense": 55303000,
    "deferredtaxassetsleaseliability": 18307000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 14510000,
    "deferredtaxassetsgoodwillandintangibleassets": 1875000,
    "deferredtaxassetsdepreciationandamortization": 568000,
    "deferredtaxassetsother": 7270000,
    "deferredtaxassetsgross": 248114000,
    "deferredtaxassetsvaluationallowance": 230518000,
    "deferredtaxassetsnet": 17596000,
    "deferredtaxliabilitiesoperatingleaseassets": 17596000,
    "deferredincometaxliabilities": 17596000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 2300000
  },
  {
    "date": "2021-12-30",
    "symbol": "RLAY",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "RELAY THERAPEUTICS, INC.",
    "entitycentralindexkey": 1812364,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large Accelerated Filer",
    "entitywellknownseasonedissuer": "Yes",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "RLAY",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39385",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "47-3923475",
    "entityaddressaddressline1": "399 Binney Street",
    "entityaddressaddressline2": "2nd Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "370-8837",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young",
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 280119000,
    "investments": 677954000,
    "accountsreceivablenetcurrent": 403000,
    "contractwithcustomerassetnet": 4537000,
    "prepaidexpenseandotherassetscurrent": 13229000,
    "assetscurrent": 976242000,
    "propertyplantandequipmentnet": 6543000,
    "operatingleaserightofuseasset": 20780000,
    "restrictedcashnoncurrent": 2578000,
    "finitelivedintangibleassetsnet": 2300000,
    "assets": 1008443000,
    "accountspayablecurrent": 8276000,
    "accruedliabilitiescurrent": 13953000,
    "operatingleaseliabilitycurrent": 1844000,
    "contractwithcustomerliabilitycurrent": 248000,
    "liabilitiescurrent": 24321000,
    "operatingleaseliabilitynoncurrent": 21056000,
    "businesscombinationcontingentconsiderationliability": 50258000,
    "otherliabilitiesnoncurrent": 15000000,
    "liabilities": 110635000,
    "commonstockvalue": 109000,
    "additionalpaidincapital": 1666887000,
    "accumulatedothercomprehensiveincomelossnetoftax": -1088000,
    "retainedearningsaccumulateddeficit": -768100000,
    "stockholdersequity": 897808000,
    "liabilitiesandstockholdersequity": 1008443000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 108210318,
    "commonstocksharesoutstanding": 108210318,
    "revenuefromcontractwithcustomerexcludingassessedtax": 3029000,
    "revenuefromcontractwithcustomerproductandserviceextensiblelist": "http://fasb.org/us-gaap/2021-01-31#LicenseAndServiceMember",
    "revenues": 30290000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 172650000,
    "researchanddevelopmentinprocess": 123000000,
    "variableinterestentityinitialconsolidationgainorloss": -11855000,
    "fairvalueadjustmentofwarrants": 2836000,
    "generalandadministrativeexpense": 57386000,
    "operatingexpenses": 367727000,
    "operatingincomeloss": -364698000,
    "interestincomeother": 830000,
    "othernonoperatingexpense": 4000,
    "othernonoperatingincomeexpense": 826000,
    "netincomeloss": -363872000,
    "netincomelossavailabletocommonstockholdersbasic": -363872000,
    "earningspersharebasicanddiluted": -3.82,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 95136719,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": -1152000,
    "othercomprehensiveincomelossnetoftax": -1152000,
    "comprehensiveincomenetoftax": -365024000,
    "sharesoutstanding": 108210318,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 43685,
    "stockissuedduringperiodvaluenewissues": 15000,
    "stockissuedduringperiodsharesnewissues": 15188679,
    "stockissuedduringperiodvaluestockoptionsexercised": 1000,
    "stockissuedduringperiodsharesstockoptionsexercised": 996536,
    "vestingofrestrictedcommonstockvalue": 3000,
    "vestingofrestrictedcommonstockshares": 160364,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 48454000,
    "stockissuedduringperiodvalueacquisitions": 2000,
    "stockissuedduringperiodsharesacquisitions": 1914219,
    "othercomprehensiveincomelosscashflowhedgegainlossbeforereclassificationaftertax": -1152000,
    "adjustmentstoadditionalpaidincapitalstockissuedownsharelendingarrangementissuancecosts": 20290000,
    "sharebasedcompensation": 48454000,
    "depreciation": 3925000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -2052000,
    "acquiredresearchanddevelopmentinprocess": 123000000,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliability1": 2836000,
    "increasedecreaseinprepaidexpense": 2681000,
    "increasedecreaseinoperatingleaseassetsandliabilitiesnet": -277000,
    "increasedecreaseinaccountspayable": 930000,
    "increasedecreaseinaccruedliabilities": 6002000,
    "increasedecreaseinaccountsreceivable": -74677000,
    "increasedecreaseincommoditycontractassetsandliabilities": -3117000,
    "increasedecreaseinotheroperatingliabilities": 15000000,
    "increasedecreaseinotheroperatingassets": -22000,
    "netcashprovidedbyusedinoperatingactivities": -74406000,
    "paymentstoacquirepropertyplantandequipment": 3471000,
    "paymentstoacquireinvestments": 980665000,
    "proceedsfromsaleandmaturityofotherinvestments": 529923000,
    "paymentstoacquirebusinessesnetofcashacquired": 25298000,
    "netcashprovidedbyusedininvestingactivities": -479511000,
    "proceedsfromissuanceofcommonstock": 4739000,
    "proceedsfromissuanceofcommonstockuponfollowonofferingnet": 382210000,
    "proceedsfromstockplans": 1141000,
    "netcashprovidedbyusedinfinancingactivities": 388090000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -165827000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 282697000,
    "capitalexpendituresincurredbutnotyetpaid": 1010000,
    "reclassificationofrestrictedstockliabilitytoadditionalpaidincapital": 3000,
    "fairvalueofassetsacquired": 662000,
    "liabilitiesassumed1": 2330000,
    "stockissued1": 62990000,
    "restrictedcash": 2578000,
    "numberofdiscoverystageprograms": 5,
    "numberofoperatingsegments": 1,
    "cashandcashequivalentsmaturitydatedescription": "The Company considers all short-term, highly liquid investments with original maturities of 90 days or less at acquisition date to be cash equivalents.",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "propertyplantandequipmentusefullife": "P3Y",
    "incometaxexaminationlikelihoodofunfavorablesettlement": "greater than 50%",
    "cashandcashequivalentsfairvaluedisclosure": 251891000,
    "investmentsfairvaluedisclosure": 469386000,
    "assetsfairvaluedisclosure": 251891000,
    "businesscombinationcontingentconsiderationliabilitymilestonespayments": 45258000,
    "nonfinancialliabilitiesfairvaluedisclosure": 45258000,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentmilestonepayments": 42422000,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentearnoutpayments": 5000000,
    "increaseinfairvalueofcontingentmilestonepayments": 2836000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 189406000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 228000,
    "availableforsalesecuritiesdebtsecurities": 189178000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionnumberofpositions": 88,
    "debtsecuritiesavailableforsaleunrealizedlossposition": 667000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardacceleratedcompensationcost": 4600000,
    "businesscombinationacquisitionrelatedcosts": 900000,
    "numberofshareswouldbeissueduponmilestoneachievement": 2817555,
    "businessacquisitionshareprice": 30.17,
    "businesscombinationcontingentconsiderationarrangementsdescription": "The Contingent Milestone Payments are payable in common shares based on a fixed amount assigned to each milestone and the weighted average share price of the Company’s stock for the 5-day period prior to the milestone achievement.",
    "collaborativearrangementnatureandpurpose": "In August 2021, the Company and EQRx, Inc. (“EQRx”) entered into the Discovery Collaboration Agreement (“Collaboration Agreement”) to discover, develop, and commercialize novel medicines against validated oncology targets.",
    "nonrefundableupfrontpayment": 75000000,
    "milestonepaymentreceivable": 5000000,
    "maximumadditionalamountreceiveduponmilestoneachievement": 695000000,
    "collaborationagreementtransactionprice": 86500000,
    "nonrefundablemilestonetransferamount": 5000000,
    "nonrefundablemilestoneforcompletionamount": 5000000,
    "variableconsiderationrelatedtoreimbursementsdueforresearchanddevelopmentservices": 1500000,
    "revenueremainingperformanceobligation": 83300000,
    "propertyplantandequipmentgross": 15797000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 14367000,
    "accruedexternalresearchanddevelopmentexpensecurrent": 10755000,
    "accruedprofessionalservicescurrent": 2613000,
    "accruedotherexpensescurrent": 585000,
    "commonstockvotingrights": "Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders.",
    "commonstockrestrictionperiod": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 3400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 691205,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 84489,
    "sharebasedcompensationbysharebasedarrangementequityinstrumentsotherthanoptionsvestedinperiodweightedaveragepriceofsharespurchased": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 9735928,
    "allocatedsharebasedcompensationexpense": 24922000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 32400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 22.95,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 53600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6906367,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2363676,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 253119,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2971597,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 3934770,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 16.8,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 34.2,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.82,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 15.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 23.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y1M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm": "P8Y6M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 111021000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 68991000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 42029000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.006,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.016,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.747,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.766,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 782299,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 15219,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 33.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 34.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 37.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.651,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 371400000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 43100000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 328300000,
    "deferredtaxassetsoperatinglosscarryforwardsbeginningtoexpireyear": 2035,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 466200000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 14900000,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationyear": 2035,
    "increaseindeferredtaxassetsvaluationallowance": 76900000,
    "incometaxexaminationdescription": "There are currently no pending tax examinations.",
    "taxcutsandjobsactof2017netoperatinglosscarrybackperiod": "P5Y",
    "caresactpercentageofeliminatesoftaxableincome": 0.8,
    "taxcutsandjobsactof2017maximumpercentageofinterestdeductedbytaxpayers": 0.5,
    "caresactpercentageofinterestdeductedbytaxpayers": 0.3,
    "caresactpercentageofcorporatecharitabledeductionlimit": 0.25,
    "caresactperiodofqualifiedimprovementpropertyforcostrecovery": "P15Y",
    "caresactpercentageofbonusdepreciation": 1,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.057,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.205,
    "effectiveincometaxratereconciliationinprocessresearchanddevelopmentasset": -0.07,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.022,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.004,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.01,
    "deferredtaxassetsoperatinglosscarryforwards": 108800000,
    "deferredtaxassetstaxcreditcarryforwards": 18288000,
    "deferredtaxassetsleaseliability": 6010000,
    "deferredtaxassetsgoodwillandintangibleassets": 1859000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 8374000,
    "deferredtaxassetsdepreciationandamortization": 477000,
    "deferredtaxassetsother": 4304000,
    "deferredtaxassetsgross": 148112000,
    "deferredtaxassetsvaluationallowance": 142674000,
    "deferredtaxassetsnet": 5438000,
    "deferredtaxliabilitiesoperatingleaseassets": -5438000,
    "deferredincometaxliabilities": 5438000,
    "incomelossfromcontinuingoperations": -363872000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 8719627,
    "convertiblepreferredstocksharesissueduponconversion": 3281253,
    "researchanddevelopmentarrangementtermofcontract": "P3Y",
    "researchanddevelopmentarrangementcontracttoperformforothersrenewalperiod": "P1Y",
    "potentialdevelopmentmilestonepayments": 7300000,
    "milestonepaymentdueuponspecifiedregulatorymilestoneachievement": 7300000,
    "researchanddevelopmentexpense": 9500000,
    "prepaidexpensecurrent": 4400000,
    "numberofmilestonetargets": 4,
    "lettersofcreditoutstandingamount": 900000,
    "debtinstrumentmaturitydate": "2028-09-30",
    "operatingleasepayments": 5400000,
    "lesseeoperatingleasetermofcontract": "P10Y",
    "operatingleaseweightedaverageremainingleaseterm1": "P7Y3M18D",
    "operatingleaseweightedaveragediscountratepercent": 0.104,
    "operatingleaserightofuseassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OperatingLeaseRightOfUseAsset",
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityCurrent",
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityNoncurrent",
    "operatingleaseliability": 22900000,
    "operatingleasecost": 3262000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 4134000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 4254000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 4377000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 4503000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 4634000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 11325000,
    "lesseeoperatingleaseliabilitypaymentsdue": 33227000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 10327000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 1200000
  },
  {
    "date": "2020-12-30",
    "symbol": "RLAY",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "RELAY THERAPEUTICS, INC.",
    "entitycentralindexkey": 1812364,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "RLAY",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39385",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "47-3923475",
    "entityaddressaddressline1": "399 Binney Street",
    "entityaddressaddressline2": "2nd Floor",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "370-8837",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 447646000,
    "investments": 230415000,
    "accountsreceivablenetcurrent": 75000000,
    "contractwithcustomerassetnet": 7654000,
    "prepaidexpenseandotherassetscurrent": 9385000,
    "assetscurrent": 770100000,
    "propertyplantandequipmentnet": 6250000,
    "operatingleaserightofuseasset": 22579000,
    "restrictedcashnoncurrent": 878000,
    "otherassets": 22000,
    "assets": 799829000,
    "accountspayablecurrent": 6351000,
    "accruedliabilitiescurrent": 1500000,
    "operatingleaseliabilitycurrent": 1521000,
    "liabilitiescurrent": 13632000,
    "operatingleaseliabilitynoncurrent": 22901000,
    "restrictedstockliability": 3000,
    "liabilities": 36536000,
    "commonstockvalueoutstanding": 90000,
    "additionalpaidincapital": 1167367000,
    "accumulatedothercomprehensiveincomelossnetoftax": 64000,
    "retainedearningsaccumulateddeficit": -404228000,
    "stockholdersequity": -404228000,
    "liabilitiesandstockholdersequity": 799829000,
    "temporaryequityparorstatedvaluepershare": 0.001,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 89991324,
    "commonstocksharesoutstanding": 89906835,
    "revenuefromcontractwithcustomerexcludingassessedtax": 82654000,
    "revenuefromcontractwithcustomerproductandserviceextensiblelist": "rlay:LicenseRevenueMember",
    "revenues": 82654000,
    "researchanddevelopmentexpense": 2704000,
    "generalandadministrativeexpense": 38588000,
    "operatingexpenses": 138450000,
    "operatingincomeloss": -55796000,
    "interestincomeother": 3400000,
    "othernonoperatingexpense": 16000,
    "othernonoperatingincomeexpense": 3384000,
    "netincomeloss": -52412000,
    "deemeddividendresultingfromextinguishmentofpreferredstock": -177789000,
    "netincomelossavailabletocommonstockholdersbasic": -230201000,
    "earningspersharebasicanddiluted": -5.4,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 42619582,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": -261000,
    "othercomprehensiveincomelossnetoftax": -261000,
    "comprehensiveincomenetoftax": -52673000,
    "sharesoutstanding": 89906835,
    "stockissuedduringperiodvaluetreasurystockreissued": -177789000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 715570000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 61992534,
    "stockissuedduringperiodvaluenewissues": 425293000,
    "stockissuedduringperiodsharesnewissues": 23000000,
    "stockissuedduringperiodvaluestockoptionsexercised": 1216000,
    "stockissuedduringperiodsharesstockoptionsexercised": 297000,
    "vestingofrestrictedcommonstockvalue": 154000,
    "vestingofrestrictedcommonstockshares": 579825,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 31960000,
    "othercomprehensiveincomeunrealizedgainlossonderivativesarisingduringperiodnetoftax": -261000,
    "adjustmentstoadditionalpaidincapitalstockissuedownsharelendingarrangementissuancecosts": 34707000,
    "sharebasedcompensation": 31960000,
    "depreciation": 3549000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 416000,
    "increasedecreaseinprepaidexpense": 4665000,
    "increasedecreaseinleaseassetsandliabilitiesnet": -571000,
    "increasedecreaseinaccountspayable": -410000,
    "increasedecreaseinaccruedliabilities": 2010000,
    "increasedecreaseinaccountsreceivable": 75000000,
    "increasedecreaseincommoditycontractassetsandliabilities": 7654000,
    "increasedecreaseinotheroperatingassets": 22000,
    "netcashprovidedbyusedinoperatingactivities": -102489000,
    "paymentstoacquirepropertyplantandequipment": 1931000,
    "paymentstoacquireinvestments": 266455000,
    "proceedsfromsaleandmaturityofotherinvestments": 350058000,
    "netcashprovidedbyusedininvestingactivities": 81672000,
    "proceedsfromissuanceofcommonstock": 1216000,
    "proceedsfromissuanceinitialpublicoffering": 427800000,
    "paymentoffinancingandstockissuancecosts": 2507000,
    "netcashprovidedbyusedinfinancingactivities": 426509000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 405692000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 448524000,
    "capitalexpendituresincurredbutnotyetpaid": 519000,
    "reclassificationofrestrictedstockliabilitytoadditionalpaidincapital": 153000,
    "lossonextinguishmentandreissuanceofpreferredstock": -177789000,
    "conversionofstockamountconverted1": 715508000,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 819000,
    "restrictedcash": 878000,
    "numberofoperatingsegments": 1,
    "cashandcashequivalentsmaturitydatedescription": "The Company considers all short-term, highly liquid investments with original maturities of 90 days or less at acquisition date to be cash equivalents.",
    "numberofcollaborationandlicenseagreement": 1,
    "collaborationandlicenseagreemententereddate": "2020-12-11",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "propertyplantandequipmentusefullife": "P5Y",
    "incometaxexaminationlikelihoodofunfavorablesettlement": "greater than 50%",
    "cashandcashequivalentsfairvaluedisclosure": 447146000,
    "investmentsfairvaluedisclosure": 230415000,
    "assetsfairvaluedisclosure": 677561000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 230351000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 64000,
    "availableforsalesecuritiesdebtsecurities": 230415000,
    "collaborativearrangementnatureandpurpose": "On December 11, 2020, the Company entered into the Genentech Agreement, which granted Genentech a license to develop and commercialize RLY-1971.",
    "collaborativearrangementrightsandobligations": "Unless Genentech elects to exercise its option to conduct the remainder of the ongoing Phase 1a Trial, the Company is responsible for the completion of this trial. Genentech is responsible for conducting all subsequent clinical development of RLY-1971. The Company is also responsible for the one-time transfer of the active pharmaceutical ingredient (“API”) and other materials related to RLY-1971 to Genentech",
    "nonrefundableupfrontpayment": 75000000,
    "milestonepaymentreceivable": 25000000,
    "maximumadditionalamountreceiveduponmilestoneachievement": 6250000,
    "collaborationagreementtransactionprice": 85867000,
    "nonrefundablemilestonetransferamount": 5000000,
    "nonrefundablemilestoneforcompletionamount": 5000000,
    "variableconsiderationrelatedtoreimbursementsdueforresearchanddevelopmentservices": 867000,
    "revenueremainingperformanceobligation": 317000000,
    "accountsreceivablenet": 75000000,
    "propertyplantandequipmentgross": 16780000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 10530000,
    "accruedexternalresearchanddevelopmentexpensecurrent": 5099000,
    "accruedprofessionalservicescurrent": 464000,
    "accruedotherexpensescurrent": 197000,
    "preferredstockconvertibleconversionprice": 22.8,
    "convertiblepreferredstocksharesissueduponconversion": 3281253,
    "proceedsfromissuanceofpreferredstockandpreferencestock": 100000000,
    "preferredstockliquidationpreference": 22.8,
    "commonstockvotingrights": "Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders.",
    "commonstockrestrictionperiod": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 9619000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 8026772,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 84489,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 579825,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 14844,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpershareweightedaveragepriceofsharespurchased": 0.04,
    "sharebasedcompensationbysharebasedarrangementequityinstrumentsotherthanoptionsvestedinperiodweightedaveragepriceofsharespurchased": 0.26,
    "sharebasedcompensationbysharebasedarrangementequityinstrumentsotherthanoptionscancelledinperiodweightedaveragepriceofsharespurchased": 0.03,
    "commonstockcapitalsharesreservedundercompensationplan": 8026772,
    "commonstockcapitalsharesreservedforfutureissuance": 8026772,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "The commencement of vesting was based on the achievement of certain scientific and operational milestones during a two-year period, for which the achievement was discretionary and subject to the approval of the Company’s board of directors.",
    "allocatedsharebasedcompensationexpense": 31960000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 30.14,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 69948000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y7M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7697058,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2898663,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 210781,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2148119,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 5548939,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.99,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.9,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.09,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 7.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaverageremainingcontractualterm": "P8Y8M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 266050000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 79625000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 186425000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.004,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.018,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.735,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.776,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 174028000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 43127000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 130901000,
    "deferredtaxassetsoperatinglosscarryforwardsbeginningtoexpireyear": 2035,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 192346000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2699000,
    "deferredtaxassetstaxcreditcarryforwardsresearchexpirationyear": 2030,
    "increaseindeferredtaxassetsvaluationallowance": 14276000,
    "incometaxexaminationdescription": "There are currently no pending tax examinations.",
    "taxcutsandjobsactof2017netoperatinglosscarrybackperiod": "P5Y",
    "caresactpercentageofeliminatesoftaxableincome": 0.8,
    "taxcutsandjobsactof2017maximumpercentageofinterestdeductedbytaxpayers": 0.5,
    "caresactpercentageofinterestdeductedbytaxpayers": 0.3,
    "caresactpercentageofcorporatecharitabledeductionlimit": 0.25,
    "caresactperiodofqualifiedimprovementpropertyforcostrecovery": "P15Y",
    "caresactpercentageofbonusdepreciation": 1,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.057,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.273,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.076,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.067,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.003,
    "deferredtaxassetsoperatinglosscarryforwards": 48832000,
    "deferredtaxassetstaxcreditcarryforwards": 10270000,
    "deferredtaxassetsleaseliability": 6430000,
    "deferredtaxassetsgoodwillandintangibleassets": 1469000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4496000,
    "deferredtaxassetsdepreciationandamortization": 230000,
    "deferredtaxassetsother": 14000,
    "deferredtaxassetsgross": 71741000,
    "deferredtaxassetsvaluationallowance": 65813000,
    "deferredtaxassetsnet": 5928000,
    "deferredtaxliabilitiesoperatingleaseassets": 5928000,
    "deferredincometaxliabilities": 5928000,
    "preferredstockdividendsandotheradjustments": 177789000,
    "incomelossfromcontinuingoperations": -230201000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7781547,
    "researchanddevelopmentarrangementtermofcontract": "P3Y",
    "researchanddevelopmentarrangementcontracttoperformforothersrenewalperiod": "P1Y",
    "potentialdevelopmentmilestonepayments": 7000000,
    "milestonepaymentdueuponspecifiedregulatorymilestoneachievement": 1500000,
    "numberofmilestonetargets": 4,
    "lettersofcreditoutstandingamount": 878000,
    "debtinstrumentmaturitydate": "2028-09-30",
    "operatingleasepayments": 4878000,
    "operatingleaseweightedaverageremainingleaseterm1": "P8Y3M18D",
    "operatingleaseweightedaveragediscountratepercent": 0.104,
    "operatingleaserightofuseassetstatementoffinancialpositionextensiblelist": "rlay:OperatingLeaseAssetsMember",
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "rlay:OperatingLeaseLiabilitiesMember",
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "rlay:OperatingLeaseLiabilitiesNetOfCurrentPortionMember",
    "operatingleaseliability": 24422000,
    "operatingleasecost": 4021000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 3985000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 4134000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 4254000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 4377000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 4503000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 15959000,
    "lesseeoperatingleaseliabilitypaymentsdue": 37212000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 12790000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 590000
  }
]